|
|
MITOMYCIN
|
|
|
|
|
|
ANTINEOPLASTICS
|
|
|
Upper gastro-intestinal and breast cancers and by bladder instillation for superficial bladder tumours.
|
|
|
Delayed bone-marrow toxicity , nausea, vomiting and anorexia, stomatitis, leukopenia, thrombocytopenia,alopecia.
|
|
|
According to disease and patient particulars.
|
|
|
|
|
|
Mitomycin can cause fetal harm in humans. Animal studies have shown delayed fetal development, fetal external anomalies, and neonatal anomalies.
|
|
|
Mitomycin is distributed into breastmilk. Breastfeeding is not recommended during therapy.
|
|
|
|